We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Gyros Expands Asian Distribution to Singapore
News

Gyros Expands Asian Distribution to Singapore

Gyros Expands Asian Distribution to Singapore
News

Gyros Expands Asian Distribution to Singapore

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Gyros Expands Asian Distribution to Singapore"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Gyros AB has announced that Bio Laboratories Pte Ltd (www.biolab.com.sg) has become sole distributor for the company’s nanoliter-scale immunoassay platform in Singapore.

The Gyros platform (www.gyros.com) is used by major biopharmaceutical companies and their service providers worldwide to improve productivity and efficiency during the development of biotherapeutics and vaccines, boosting time-critical workflows and helping to meet regulatory demands.

“We are very pleased to expand our reach in Asia through this new partnership with Bio Laboratories, which provides a valuable addition to our recently announced collaboration with GE Healthcare for distribution in Japan, China, Taiwan and Hong Kong,” commented Erik Walldén, CEO, Gyros.

Walldén continued, “As our immunoassay platform increases in acceptance within the biopharmaceutical industry, it is ever more vital that we have an experienced and respected network of distributors to ensure the highest possible standards of service and support for our customers.”

Benny Wee, Managing Director, Bio Laboratories, said, “The Gyros immunoassay platform is an excellent addition to our extensive range of distribution agreements with high quality, innovative analytical instrument providers. We are delighted to be able to now offer Gyros’ products to the biopharmaceutical industry in Singapore.”

Advertisement